AHMEDABAD, 14 OCTOBER: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

JP Morgan on Larsen: Initiate Overweight on Company, target price at Rs 4360 (Positive)

HSBC on BPCL: Maintain Buy on Company, target price at Rs 460 (Positive)

HSBC on HPCL: Maintain Buy on Company, target price at Rs 480 (Positive)

HSBC on IOCL: Maintain Buy on Company, target price at Rs 200 (Positive)

Emkay on Vedanta: Initiate Buy on Company, target price at Rs 600 (Positive)

Emkay on NALCO: Initiate Buy on Company, target price at Rs 275 (Positive)

ICICI on Jana SFB: Initiate Add on Company, target price at Rs 630 (Positive)

MS on Life Insurance stocks: APE for private insurers grew at 28% on a base of 12% (Positive)

Nomura on Life Insurance stocks: Nomura says growth of public insurance players outpaced overall industry in Sep 2024 (Positive)

Kotak Securities on Pharma Sector: Indian Pharma Market posted growth of 8% YoY in Q2, driven by slower growth in acute therapies (Neutral)

Emkay on Hindalco: Initiate Reduce on Company, target price at Rs 650 (Neutral)

Citi on Just Dial: Maintain Sell on Company, raise target price at Rs 1075 (Neutral)

MOSL on DMart: Maintain Buy on Company, target price at Rs 5300 (Neutral)

Bernstein on DMart: Maintain Outperform on Company, target price at Rs 5800 (Neutral)

Nuvama on DMart: Maintain Buy on Company, target price at Rs 5040 (Neutral)

Citi on DMart: Maintain Sell on Company, target price at Rs 3500 (Negative)

JP Morgan on DMart: Downgrade to Underweight on Company, target price at Rs 3702 (Negative)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)